Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial

BACKGROUND: There are presently no available therapeutic options for peanut-allergic patients. OBJECTIVE: To investigate the safety, efficacy, and immunologic effects of peanut sublingual immunotherapy (SLIT). METHODS: After a baseline oral food challenge (OFC) of up to 2g of peanut powder (~50% pro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Fleischer, David M., Burks, A. Wesley, Vickery, Brian P., Scurlock, Amy M., Wood, Robert A., Jones, Stacie M., Sicherer, Scott H., Liu, Andrew H., Stablein, Donald, Henning, Alice K., Mayer, Lloyd, Lindblad, Robert, Plaut, Marshall, Sampson, Hugh A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3550002/
https://ncbi.nlm.nih.gov/pubmed/23265698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2012.11.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller